Bill > A06621

This bill proposes to amend the cannabis law by establishing new restrictions on cannabinoid hemp products, specifically limiting their sale based on the ratio of cannabidiol (CBD) to tetrahydrocannabinol (THC). Under the proposed legislation, cannabinoid hemp products (with the exception of flower and topical products) would be prohibited from having a CBD to THC ratio lower than 15:1. If CBD is not the primary marketed cannabinoid, the bill requires that the sum of all cannabinoids excluding THC must have a ratio of at least 15:1 to THC. This means that products with higher concentrations of THC relative to other cannabinoids would be banned from sale. The purpose appears to be regulating the potency and psychoactive potential of hemp-derived products by ensuring a significantly higher proportion of non-intoxicating cannabinoids like CBD compared to THC. The bill would take effect immediately upon enactment.

Business and Industry

https://www.nysenate.gov/legislation/bills/2025/A6621